Umbilical Cord Blood Transplantation for Thalassemia Major

Sep 18, 2017 by in HEMATOLOGY Comments Off on Umbilical Cord Blood Transplantation for Thalassemia Major

Hematopoietic cell transplantation is curative therapy for thalassemia major. Although the clinical application of hematopoietic cell transplantation has relied on marrow collected from related and unrelated donors as the primary…

read more

Allogeneic Cellular Gene Therapy for Hemoglobinopathies

Sep 18, 2017 by in HEMATOLOGY Comments Off on Allogeneic Cellular Gene Therapy for Hemoglobinopathies

Hematopoietic stem cell transplantation (HSCT) offers potentially curative therapy for patients with thalassemia major and sickle cell disease (SCD). Current myeloablative treatment protocols allow the cure of 78% to 90%…

read more

Pharmacologic Induction of Fetal Hemoglobin Production

Sep 18, 2017 by in HEMATOLOGY Comments Off on Pharmacologic Induction of Fetal Hemoglobin Production

Reactivation of fetal hemoglobin (HbF) expression is an important therapeutic option in adult patients with hemoglobin disorders. The understanding of the developmental regulation of γ-globin gene expression was followed by…

read more

Iron Overload in Thalassemia and Related Conditions: Therapeutic Goals and Assessment of Response to Chelation Therapies

Sep 18, 2017 by in HEMATOLOGY Comments Off on Iron Overload in Thalassemia and Related Conditions: Therapeutic Goals and Assessment of Response to Chelation Therapies

Transfusional iron loading inevitably results in hepatic iron accumulation, with variable extrahepatic distribution that is typically less pronounced in sickle cell disease than in thalassemia disorders. Iron chelation therapy has…

read more

Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in β-Thalassemia

Sep 18, 2017 by in HEMATOLOGY Comments Off on Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in β-Thalassemia

β-Thalassemia is a genetic disorder caused by mutations in the β-globin gene and characterized by chronic anemia caused by ineffective erythropoiesis, and accompanied by a variety of serious secondary complications…

read more
Get Clinical Tree app for offline access